title: Passive immunity against diarrhoea.
abstract: Passive immunity against a variety of respiratory and gastrointestinal pathogens has recently been increasingly used clinically, and oral administration of antibodies of both human and non-human origin has been tried both for prophylaxis and treatment of infections. Although the former type of therapy has been shown to be effective, data on the latter are still scarce. This commentary focuses on recent studies on successful oral therapeutic administration of bovine immunoglobulins.
authors.affiliation: Department of Clinical Immunology, Huddinge Hospital, Sweden.
authors.forename: A K
authors.initials: AK
authors.lastname: Bogstedt
authors.forename: K
authors.initials: K
authors.lastname: Johansen
authors.forename: H
authors.initials: H
authors.lastname: Hatta
authors.forename: M
authors.initials: M
authors.lastname: Kim
authors.forename: T
authors.initials: T
authors.lastname: Casswall
authors.forename: L
authors.initials: L
authors.lastname: Svensson
authors.forename: L
authors.initials: L
authors.lastname: Hammarström
mesh_terms: D000818:Animals; D002417:Cattle; D003967:Diarrhea / Q000188:drug therapy / Q000517:prevention & control* / Q000821:virology; D001908:Diarrhea Viruses, Bovine Viral / Q000276:immunology* / Q000302:isolation & purification; D006801:Humans; D007116:Immunization, Passive; D007070:Immunoglobulin A / Q000276:immunology; D007136:Immunoglobulins / Q000008:administration & dosage / Q000627:therapeutic use; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000517:prevention & control / Q000821:virology
chemical_list: D007070:Immunoglobulin A; D007136:Immunoglobulins